Delivery Order SPE2DB24D2205-SPE2DB25FEFZH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,747.80 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with the DLA. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $10,402.76 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for Advair HFA 115-21 microgram inhaler 12-gram units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 gram units) with a ceiling value of $1,476.11. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a $1,900.89 delivery order to AmerisourceBergen Drug Corp for Advair HFA 115-21 microgram inhaler (12 grams) under a firm fixed price contract type. The contract was competitively awarded without a set-aside designation and carries an ultimate completion date of July 23, 2025, one day after the award date of July 22, 2025. Performance will take place at the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued against...
- The Defense Logistics Agency awarded a delivery order valued at $2,618.19 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,952.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Advair HFA 45-21 mcg inhaler (12 gm units) with a completion date of July 31, 2025. This non-set-aside contract was competitively awarded and reflects a routine pharmaceutical procurement through the DLA's medical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,956.40 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Advair HFA 230-21 micrograms inhalers (12-gram units). This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global...
- The Defense Logistics Agency awarded a $14,025.54 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm). This is a firm fixed price delivery order with no set-aside designation, issued as a competitively awarded contract. The order is scheduled for ultimate completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This contract represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $12,282.72 to AmerisourceBergen Drug Corp for Advair HFA 230-21 microgram inhalers (12 grams) with a firm fixed price and no set-aside designation. The award was made on August 8, 2025, with an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply delivery. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 9, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm), a commonly prescribed bronchodilator medication used in respiratory care. This firm fixed-price delivery order, valued at $4,376.72, represents a non-competitive award and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The place of performance is listed as Conshohocken,...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFZHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,207.05 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, issued on August 7, 2025, was competitively awarded with no set-aside designation. The pharmaceutical product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical supplier for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's contract portfolio demonstrates extensive experience fulfilling federal medical supply needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies for customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.2k | 8/7/25 |